Page last updated: 2024-08-24

zileuton and Carcinoma, Renal Cell

zileuton has been researched along with Carcinoma, Renal Cell in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chiasson, A; Cormier, M; Dastous, S; Doiron, JA; Lyons, P; Selka, A; Surette, ME; Touaibia, M; Turcotte, S1

Other Studies

1 other study(ies) available for zileuton and Carcinoma, Renal Cell

ArticleYear
Discovery of a novel 2,5-dihydroxycinnamic acid-based 5-lipoxygenase inhibitor that induces apoptosis and may impair autophagic flux in RCC4 renal cancer cells.
    European journal of medicinal chemistry, 2019, Oct-01, Volume: 179

    Topics: Antineoplastic Agents; Apoptosis; Arachidonate 5-Lipoxygenase; Carcinoma, Renal Cell; Cell Proliferation; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Drug Discovery; Drug Screening Assays, Antitumor; HEK293 Cells; Humans; Kidney Neoplasms; Lipoxygenase Inhibitors; Molecular Structure; Neutrophils; Structure-Activity Relationship

2019
chemdatabank.com